Carvedilol 25 MG Oral Tablet — RxCUI 200033
RxNorm drug concept · Semantic clinical drug
RxCUI 200033
Semantic clinical drug · SCD
● Current RxNorm concept 110 FDA products
304 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI200033
Official nameCarvedilol 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped110
Package NDCs mapped304
Reported Medicaid activity (SDUD)2,196,428 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Carvedilol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Carvedilol works by blocking two sets of receptors — beta-receptors and alpha-1 receptors — in your heart and blood vessels. This slows your heart rate, reduces how hard your heart...
- What is carvedilol actually doing for my heart?
- Taking carvedilol with food slows down how quickly it's absorbed into your bloodstream. That matters because one of its side effects is dizziness or a drop in blood pressure when y...
- Please don't stop carvedilol suddenly without talking to your doctor first — this is one of the most important things to know about this medication. Abruptly stopping it, especiall...
🕸️ Concept Web — How Carvedilol 25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Carvedilol 25 MG Oral Tablet
RxCUI 200033 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Carvedilol
20352IN
-
Carvedilol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Coreg
216221BN
-
Coreg
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carvedilol Oral Tablet
371296SCDF -
Carvedilol Oral Product
1160589SCDG -
Carvedilol Pill
1160590SCDG -
Carvedilol Oral Tablet [Coreg]
368387SBDF -
Coreg Oral Product
1169532SBDG -
Coreg Pill
1169533SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Carvedilol Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Carvedilol 25 MG
315576SCDC -
Carvedilol 25 MG Oral Tablet [Coreg]
212390SBD -
Carvedilol 25 MG [Coreg]
572583SBDC
-
Carvedilol 25 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Carvedilol 25 MG
SCDC · 315576 -
Carvedilol Oral Tablet
SCDF · 371296 -
Carvedilol Oral Product
SCDG · 1160589 -
Carvedilol Pill
SCDG · 1160590
Brand-Name Concepts
-
Carvedilol 25 MG Oral Tablet [Coreg]
SBD · 212390 -
Carvedilol 25 MG [Coreg]
SBDC · 572583 -
Carvedilol Oral Tablet [Coreg]
SBDF · 368387 -
Coreg Oral Product
SBDG · 1169532 -
Coreg Pill
SBDG · 1169533 -
Coreg
BN · 216221
📦 FDA Products & Package NDCs
110 products · 304 package NDCs
304 package NDCs map to RxCUI 200033 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 82009-0128-05 | 500 TABLET, FILM COATED in 1 BOTTLE (82009-128-05) | Carvedilol | Quallent Pharmaceuticals Health LLC | 2023-08-03 |
| 82804-0138-60 | 60 TABLET, FILM COATED in 1 BOTTLE (82804-138-60) | Carvedilol | Proficient Rx LP | 2025-12-04 |
| 82804-0138-90 | 90 TABLET, FILM COATED in 1 BOTTLE (82804-138-90) | Carvedilol | Proficient Rx LP | 2024-09-06 |
| 82804-0183-90 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82804-183-90) | Carvedilol | Proficient Rx LP | 2025-02-04 |
Observed labelers:
Bryant Ranch Prepack (55) ·
A-S Medication Solutions (29) ·
Dr. Reddy's Laboratories Limited (20) ·
Glenmark Pharmaceuticals Inc., USA (20) ·
Advagen Pharma Ltd (16) ·
Advagen Pharma Limited (12)
· +24 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.